Featured publication

Tracking the developments in the fields of law and economics, public policy, and business strategy.

FALL 2025

View Issue

Search Insights

Latest Insights

Article  |  January 27, 2026

The Class Action Implications of AI-Driven Decisions

On May 16, 2025, United States District Judge Rita Lin granted a Motion for Conditional Certification of Collective Action in Mobley v. Workday, Inc. The Plaintiff alleges age, race, and disability discrimination from Workday’s AI-driven human resources tools that generate hiring recommendations.

Read More
Article  |  January 27, 2026

Navigating Battery Validation Risk in the EV Supply Chain 

Writing for Law360, Director Sam Madden and Vanessa Miller of Foley & Lardner explore how battery validation delays, evolving technical standards, and performance uncertainty are increasingly at the heart of contract disputes, regulatory scrutiny, and litigation. 

Read More

See All Insights

Events

Brand Protection & Piracy in Sport

January 27, 2026

On 27 January, Associate Director Shalabh Gupta will moderate the session “Drilling Down the Detail for Sport Brands” at the Brand Protection & Piracy in Sport in-house counsel seminar hosted by LawInSport and Stobbs.

Read More

The 2026 NABE Econ and Law Summit

January 26, 2026 – January 27, 2026

Managing Directors Jennifer Vanderhart and Matt Farber will be speaking during the NABE Econ and Law Summit, contributing to discussions at the intersection of economics, law, and public policy.

Read More
See All Events
featured Engagements

Eric Poer Reflects on a Historic Forensic Investigation That Drove Sweeping Reforms at Wells Fargo in the Wake of Historic Fraud Scandal 

Eric Poer, an internationally-recognized forensic accounting, investigations, and disputes expert, led the forensic accounting and data analytics team retained to support A&O Shearman in conducting an independent investigation into Wells Fargo’s sales practices—an inquiry launched in response to one of the most significant financial consumer fraud scandals in U.S. history.

Read More
View All Engagements
featured Engagements

Biopharmaceutical Reasonable Royalties on Trial

When our client, a biopharmaceutical company, had exclusively licensed a patent for a novel type of cancer immunotherapy, a competitor undertook substantial efforts to be first to market for its lead indication despite being aware of potential infringement claims against its therapy. Upon the competitor achieving FDA approval, our client filed patent infringement claims. After an eight-day trial, the jury returned a verdict in favor of our client with a damages award that precisely matched the trial testimony.

Read More
View All Engagements

Media Contact

If you would like to schedule an interview or would like more information about our firm and individual experts, please contact:

Nathan Jenks
Director of Marketing & Communications
Email: njenks@secretariat-intl.com